EMR vs Syrian Arab Republic: Hepatitis B surface antigen (HBsAg) prevalence
EMR
0.5%
in 2024
Syrian Arab Republic
2.9%
in 2024
EMR rank
4th
Syrian Arab Republic rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- EMR
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 2.9% against 0.5% in EMR, a difference of 2.4%.
That makes Syrian Arab Republic's figure about 5.8 times EMR's.
Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.
EMR ranks 4th and Syrian Arab Republic ranks 6th of 13 groups.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EMR | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 3.5% | 2.9% | Syrian Arab Republic |
| 2020s | 0.5% | 3.4% | 2.9% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EMR or Syrian Arab Republic?
- Syrian Arab Republic, at 2.9% against 0.5% in EMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EMR and Syrian Arab Republic?
- 2.4%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for EMR and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do EMR and Syrian Arab Republic rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EMR ranks 4th and Syrian Arab Republic ranks 6th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.